Literature DB >> 17689746

Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell.

Lan Yao, Kai Huang, Dsan Huang, Jing Wang, Heping Guo, Yuhua Liao.   

Abstract

Systemic inflammatory response to acute myocardial infarction (AMI) is detrimental to heart function. In this study, we proved that poly(ADP-ribose) polymerase (PARP) activity of circulating mononuclear cell (MNC) increased significantly in post-AMI patients. MNC PARP activity was correlated positively with plasma tumor necrosis factor-alpha (TNF-alpha) level, interleukin-10 (IL-10) level and the ratio of plasma TNF-alpha/IL-10 respectively. On the contrary, MNC PARP activity was correlated negatively with left ventricular ejection fraction and left ventricular fractional shortening which were measured with echocardiography in the same day when blood sample was collected. These results implicated that activation of PARP in MNC contributes to the increases in plasma TNF-alpha and IL-10 and is associated with systolic dysfunction of heart after AMI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689746     DOI: 10.1016/j.ijcard.2007.06.069

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice.

Authors:  Prasanna Krishnamurthy; Erin Lambers; Suresh Verma; Tina Thorne; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

Review 2.  STAT3 and cardiac remodeling.

Authors:  Arash Haghikia; Britta Stapel; Melanie Hoch; Denise Hilfiker-Kleiner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.

Authors:  Mira Jung; Yonggang Ma; Rugmani Padmanabhan Iyer; Kristine Y DeLeon-Pennell; Andriy Yabluchanskiy; Michael R Garrett; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

Review 4.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

5.  IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.

Authors:  Prasanna Krishnamurthy; Johnson Rajasingh; Erin Lambers; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  Circ Res       Date:  2008-12-18       Impact factor: 17.367

Review 6.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

7.  Interleukin 10 Attenuates Angiotensin II-Induced Aortic Remodelling by Inhibiting Oxidative Stress-Induced Activation of the Vascular p38 and NF-κB Pathways.

Authors:  Ming Qiu; Huanyu Shu; Lu Li; Yejiao Shen; Yunfan Tian; Yue Ji; Wei Sun; Yan Lu; Xiangqing Kong
Journal:  Oxid Med Cell Longev       Date:  2022-04-26       Impact factor: 7.310

8.  ADP-ribosylation signalling and human disease.

Authors:  Luca Palazzo; Petra Mikolčević; Andreja Mikoč; Ivan Ahel
Journal:  Open Biol       Date:  2019-04-26       Impact factor: 6.411

9.  Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).

Authors:  Gabriella Masszi; Eszter Maria Horvath; Robert Tarszabo; Rita Benko; Agnes Novak; Anna Buday; Anna-Maria Tokes; Gyorgy L Nadasy; Peter Hamar; Zoltán Benyó; Szabolcs Varbiro
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.

Authors:  Eugenia Hovsepian; Federico Penas; Sofía Siffo; Gerardo A Mirkin; Nora B Goren
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.